Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_assertion description "[Diazoxide is the first-line drug for the rare forms of CHI for long-term treatment but is not entirely effective in some of these rarer defects (GCK, MCT1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_assertion evidence source_evidence_literature NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_assertion SIO_000772 21186003 NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_assertion wasDerivedFrom befree-20140225 NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_assertion wasGeneratedBy ECO_0000203 NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP670594.RAbGJnZ0Cc7z3woOyoiZHrNQkIW1tvgYN8SEvN5vE23Oc130_provenance.